` NRC (National Research Corp) vs S&P 500 Comparison - Alpha Spread

NRC
vs
S&P 500

Over the past 12 months, NRC has underperformed S&P 500, delivering a return of +6% compared to the S&P 500's +14% growth.

Stocks Performance
NRC vs S&P 500

Loading
NRC
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NRC vs S&P 500

Loading
NRC
S&P 500
Difference
www.alphaspread.com

Performance By Year
NRC vs S&P 500

Loading
NRC
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
National Research Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

National Research Corp
Glance View

Market Cap
423.7m USD
Industry
Health Care

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 511 full-time employees. The Company’s purpose is to enable human understanding. Its solutions enable healthcare organizations to understand what matters most to each person they serve. The Company’s portfolio of solutions represents a set of capabilities that individually and collectively provide value to its clients. The Company’s portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. Its clients include integrated health systems, post-acute providers and payer organizations.

NRC Intrinsic Value
19.79 USD
Undervaluation 6%
Intrinsic Value
Price
Back to Top